Question 1

What is the catalog number for RPL35AP CRISPR Knock Out 293T Cell Line (Human)?

Accepted Answer

The catalog number for RPL35AP CRISPR Knock Out 293T Cell Line (Human) is 41487141.

Question 2

What sizes are available for RPL35AP CRISPR Knock Out 293T Cell Line (Human)?

Accepted Answer

RPL35AP CRISPR Knock Out 293T Cell Line (Human) is available in the following size(s): 1x 10^6 Cells / 1.0 mL.

Question 3

Is RPL35AP CRISPR Knock Out 293T Cell Line (Human) in stock?

Accepted Answer

RPL35AP CRISPR Knock Out 293T Cell Line (Human) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Can this product be used for diagnostic or therapeutic purposes?

Accepted Answer

No. This product, like all items we supply, is intended for research laboratory use only and must not be used for diagnostics, therapeutics, treatment, or consumption by humans or animals.

Question 5

What is the shelf life of this product?

Accepted Answer

Shelf life and expiration dates vary by product and are shown on the product listing and label. Products used beyond their expiration date are not eligible for performance-related returns or refunds, so please check the lot number and expiry before use.

Question 6

What expression system was used for this recombinant protein?

Accepted Answer

The expression system, such as E. coli, HEK293, or insect cells, is listed on the datasheet under production details, which can affect post-translational modifications relevant to your application.

RPL35AP CRISPR Knock Out 293T Cell Line (Human)

Product Specifications

Gene Name

Accession Number

Reactivity

Shipping Conditions

Storage Conditions

Frequently Asked Questions

Explore Other Products

CD95 (B-R18), CF594 conjugate, 0.1mg/mL

Cytokeratin, LMW (AE-1), CF568 conjugate, 0.1mg/mL

ACTH (Adrenocorticotrophic Hormone) (AH26), CF488A conjugate, 0.1mg/mL

CD11a (Cris-3), CF647 conjugate, 0.1mg/mL

Calretinin / Calbindin 2 (Mesothelioma Marker) (CALB2/2685), CF640R conjugate, 0.1mg/mL

MHC II (HLA-DRA) (19-26.1), CF647 conjugate, 0.1mg/mL